tetano
Editor, Senior Moderator
NPJ Vaccines
. 2021 Dec 9;6(1):149.
doi: 10.1038/s41541-021-00415-3.
Enhanced isolation of influenza viruses in qualified cells improves the probability of well-matched vaccines
Heidi Peck[SUP] #[/SUP][SUP] 1 [/SUP], Karen L Laurie[SUP] #[/SUP][SUP] 2 [/SUP], Steve Rockman[SUP] 3 4 [/SUP], Vivian Leung[SUP] 5 [/SUP], Hilda Lau[SUP] 5 [/SUP], Sally Soppe[SUP] 5 [/SUP], Cleve Rynehart[SUP] 5 [/SUP], Chantal Baas[SUP] 3 [/SUP], Heidi Trusheim[SUP] 6 [/SUP], Ian G Barr[SUP] 5 4 [/SUP]
Affiliations
Abstract
Influenza vaccines are utilised to combat seasonal and pandemic influenza. The key to influenza vaccination currently is the availability of candidate vaccine viruses (CVVs). Ideally, CVVs reflect the antigenic characteristics of the circulating virus, which may vary depending upon the isolation method. For traditional inactivated egg-based vaccines, CVVs are isolated in embryonated chicken eggs, while for cell-culture production, CVV's are isolated in either embryonated eggs or qualified cell lines. We compared isolation rates, growth characteristics, genetic stability and antigenicity of cell and egg CVV's derived from the same influenza-positive human clinical respiratory samples collected from 2008-2020. Influenza virus isolation rates in MDCK33016PF cells were twice that of eggs and mutations in the HA protein were common in egg CVVs but rare in cell CVVs. These results indicate that fully cell-based influenza vaccines will improve the choice, match and potentially the effectiveness, of seasonal influenza vaccines compared to egg-based vaccines.
. 2021 Dec 9;6(1):149.
doi: 10.1038/s41541-021-00415-3.
Enhanced isolation of influenza viruses in qualified cells improves the probability of well-matched vaccines
Heidi Peck[SUP] #[/SUP][SUP] 1 [/SUP], Karen L Laurie[SUP] #[/SUP][SUP] 2 [/SUP], Steve Rockman[SUP] 3 4 [/SUP], Vivian Leung[SUP] 5 [/SUP], Hilda Lau[SUP] 5 [/SUP], Sally Soppe[SUP] 5 [/SUP], Cleve Rynehart[SUP] 5 [/SUP], Chantal Baas[SUP] 3 [/SUP], Heidi Trusheim[SUP] 6 [/SUP], Ian G Barr[SUP] 5 4 [/SUP]
Affiliations
- PMID: 34887440
- DOI: 10.1038/s41541-021-00415-3
Abstract
Influenza vaccines are utilised to combat seasonal and pandemic influenza. The key to influenza vaccination currently is the availability of candidate vaccine viruses (CVVs). Ideally, CVVs reflect the antigenic characteristics of the circulating virus, which may vary depending upon the isolation method. For traditional inactivated egg-based vaccines, CVVs are isolated in embryonated chicken eggs, while for cell-culture production, CVV's are isolated in either embryonated eggs or qualified cell lines. We compared isolation rates, growth characteristics, genetic stability and antigenicity of cell and egg CVV's derived from the same influenza-positive human clinical respiratory samples collected from 2008-2020. Influenza virus isolation rates in MDCK33016PF cells were twice that of eggs and mutations in the HA protein were common in egg CVVs but rare in cell CVVs. These results indicate that fully cell-based influenza vaccines will improve the choice, match and potentially the effectiveness, of seasonal influenza vaccines compared to egg-based vaccines.